Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
JTA was delisted on the 19th of November, 2021.
0 hedge funds and large institutions have $0 invested in Nuveen Tax-Advantaged Total Return Strategy Fund in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.
100% less funds holding
Funds holding: 27 → 0 (-27)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $30.3M → $0 (-$30.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 26
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.58M |
| 2 |
HBCM
Heron Bay Capital Management
Bloomfield Hills,
Michigan
|
-$6.08M |
| 3 |
Morgan Stanley
New York
|
-$5M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.1M |
| 5 |
SFS
Shaker Financial Services
Arlington,
Virginia
|
-$953K |
JTA Hedge Fund Activity: Q4 2021 in Review
0 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Nuveen Tax-Advantaged Total Return Strategy Fund (JTA) for Q4 2021, worth a combined $0 — down 100% from $30.3M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of JTA and 0 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $9.58M sold.
- 0 institutional investors held Nuveen Tax-Advantaged Total Return Strategy Fund (JTA) as of Q4 2021, down from 27 in Q3 2021.
- Funds reported $0 of Nuveen Tax-Advantaged Total Return Strategy Fund stock for Q4 2021, down 100% quarter-over-quarter.
- 0 funds opened new Nuveen Tax-Advantaged Total Return Strategy Fund positions in Q4 2021 and 26 closed out, a net change of -26 holders.
- The largest Nuveen Tax-Advantaged Total Return Strategy Fund seller in Q4 2021 was UBS Group, an estimated $9.58M sold.
Based on aggregated 13F filings for Q4 2021.